A detailed history of Westfield Capital Management CO LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Westfield Capital Management CO LP holds 4,493,833 shares of RCKT stock, worth $51.4 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
4,493,833
Previous 4,327,922 3.83%
Holding current value
$51.4 Million
Previous $93.2 Million 10.92%
% of portfolio
0.39%
Previous 0.47%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$17.6 - $25.88 $2.92 Million - $4.29 Million
165,911 Added 3.83%
4,493,833 $83 Million
Q2 2024

Aug 14, 2024

BUY
$20.66 - $26.72 $7.1 Million - $9.19 Million
343,892 Added 8.63%
4,327,922 $93.2 Million
Q1 2024

May 10, 2024

BUY
$26.16 - $30.74 $1.1 Million - $1.3 Million
42,171 Added 1.07%
3,984,030 $107 Million
Q4 2023

Feb 09, 2024

SELL
$16.78 - $31.94 $4.23 Million - $8.05 Million
-252,137 Reduced 6.01%
3,941,859 $118 Million
Q3 2023

Nov 13, 2023

BUY
$15.07 - $24.05 $8.11 Million - $12.9 Million
538,209 Added 14.72%
4,193,996 $85.9 Million
Q2 2023

Aug 11, 2023

BUY
$16.59 - $23.6 $6.97 Million - $9.91 Million
419,879 Added 12.98%
3,655,787 $72.6 Million
Q1 2023

May 12, 2023

BUY
$15.79 - $22.6 $5.22 Million - $7.47 Million
330,353 Added 11.37%
3,235,908 $55.4 Million
Q4 2022

Feb 13, 2023

BUY
$15.5 - $22.76 $3.91 Million - $5.74 Million
252,353 Added 9.51%
2,905,555 $56.9 Million
Q3 2022

Nov 14, 2022

SELL
$12.37 - $18.41 $8.66 Million - $12.9 Million
-700,191 Reduced 20.88%
2,653,202 $42.3 Million
Q2 2022

Aug 12, 2022

BUY
$7.96 - $16.64 $9.23 Million - $19.3 Million
1,159,668 Added 52.86%
3,353,393 $46.1 Million
Q1 2022

May 16, 2022

BUY
$13.16 - $23.68 $2.05 Million - $3.69 Million
155,734 Added 7.64%
2,193,725 $34.8 Million
Q4 2021

Feb 10, 2022

BUY
$21.52 - $36.02 $247,695 - $414,590
11,510 Added 0.57%
2,037,991 $44.5 Million
Q3 2021

Nov 12, 2021

SELL
$27.42 - $48.97 $1.39 Million - $2.48 Million
-50,614 Reduced 2.44%
2,026,481 $60.6 Million
Q2 2021

Aug 10, 2021

BUY
$39.41 - $47.25 $16.3 Million - $19.5 Million
413,443 Added 24.85%
2,077,095 $92 Million
Q1 2021

May 14, 2021

BUY
$43.34 - $65.91 $2.98 Million - $4.53 Million
68,671 Added 4.31%
1,663,652 $73.8 Million
Q4 2020

Feb 12, 2021

BUY
$23.3 - $59.57 $2.25 Million - $5.75 Million
96,488 Added 6.44%
1,594,981 $87.5 Million
Q3 2020

Nov 13, 2020

SELL
$20.5 - $28.59 $4.37 Million - $6.09 Million
-213,008 Reduced 12.45%
1,498,493 $34.3 Million
Q2 2020

Aug 13, 2020

BUY
$13.32 - $22.61 $400,492 - $679,814
30,067 Added 1.79%
1,711,501 $35.8 Million
Q1 2020

May 14, 2020

BUY
$9.71 - $25.11 $8.58 Million - $22.2 Million
883,838 Added 110.81%
1,681,434 $23.5 Million
Q4 2019

Feb 13, 2020

BUY
$11.07 - $24.23 $127,105 - $278,208
11,482 Added 1.46%
797,596 $18.2 Million
Q3 2019

Nov 08, 2019

BUY
$10.85 - $14.78 $2.41 Million - $3.28 Million
221,982 Added 39.35%
786,114 $9.16 Million
Q2 2019

Aug 13, 2019

BUY
$15.0 - $19.81 $8.46 Million - $11.2 Million
564,132 New
564,132 $8.46 Million
Q4 2018

Feb 08, 2019

SELL
$11.21 - $23.53 $167,029 - $350,597
-14,900 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$18.5 - $25.49 $275,650 - $379,801
14,900 New
14,900 $367,000

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $865M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Westfield Capital Management CO LP Portfolio

Follow Westfield Capital Management CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Westfield Capital Management CO LP with notifications on news.